S. Birring

发表

Comparison of airway immunopathology of eosinophilic bronchitis and asthma

I. Pavord, S. Birring, F. Symon, 2003, Thorax.

P8 Objective Cough Frequency Monitoring In Bronchiectasis

R. Garrod, A. Spinou, S. Birring, 2014, Thorax.

S27 A placebo-controlled, double-blind, randomised, crossover study to assess the efficacy, safety and tolerability of TRPV4 inhibitor GSK2798745 in participants with chronic cough

S. Birring, L. Mcgarvey, J. Smith, 2019, What’s new? Clinical trials in lung disease.

Assessment of gender differences in health status with the Leicester Cough Questionnaire (LCQ)

S. Birring, I. Pavord, 2009, Thorax.

Day time cough counts using the Leicester Cough Monitor (LCM) in patients with chronic cough and healthy controls

I. Pavord, Sérgio Matos, S. Birring, 2003 .

A case of cough, lymphocytic bronchoalveolitis and coeliac disease with improvement following a gluten free diet

I. Pavord, F. Symon, C. Brightling, 2002, Thorax.

P63 Neural respiratory drive and breathlessness intensity relationships during acute and recovery phases of exacerbations of chronic obstructive pulmonary disease

S. Birring, J. Moxham, I. Patel, 2018, In depth characterisation of COPD.

S29 Cough frequency and morbidity in inpatients with acute respiratory disease

Sérgio Matos, S. Birring, R. Turner, 2013, Thorax.

Antitussive Drugs—Past, Present, and Future

S. Birring, J. Smith, S. Birring, 2014, Pharmacological Reviews.

Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)

Sally J. Singh, I. Pavord, S. Birring, 2003, Thorax.

Clinical phenotypes and therapeutic responses in cutaneous‐predominant sarcoidosis: 6‐year experience in a tertiary referral service

P. Brex, S. Birring, S. Walsh, 2021, Clinical and experimental dermatology.

P103 The urge to cough in copd

S. Birring, I. Patel, P. Cho, 2017, Thorax.

Daily cough frequency in tuberculosis and association with household infection.

Sérgio Matos, S. Birring, H. Kunst, 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Twenty-four hour face mask sampling in pulmonary tuberculosis reveals three distinct patterns of bacterial aerosol production dissociated from conventional markers of transmission risk

M. Barer, S. Birring, A. Stoltz, 2018 .

Improvements in Cough Frequency Over 24 Hours with BLU-5937, a Selective P2X3 Antagonist, in Patient Subgroups Defined by Baseline Awake Cough Frequencies

S. Birring, C. Bonuccelli, L. Mcgarvey, 2022, A6. A006 HOT TAKES FROM CLINICAL TRIALS IN LUNG DISEASE.

S79 Cough Prevalence And Frequency In Pulmonary Tuberculosis

Sérgio Matos, S. Birring, G. Bothamley, 2014, Thorax.

Efficacy in SOOTHE, A Phase 2b Trial of BLU-5937 In Refractory Chronic Cough, Was Not Dependant of Taste Disturbance Adverse Events

S. Birring, C. Bonuccelli, A. Goldsobel, 2022, 05.01 - Airway pharmacology and treatment.